Nanovis develops nano-technology-based spinal implants with its proprietary nanoVIS Ti Surface Technology that improves the integration of orthopedic, spinal, and dental implants. The company's FortiCore interbody fusion devices feature deeply porous scaffold and nano-patterned surfaces. Nanovis has achieved regulatory clearance for the industry's first nanotechnology-designated PEEK interbody with porous titanium endplates and the first nanotechnology designation on pedicle screws. Founded in 2006 and headquartered in Columbia City, Indiana, the company has raised approximately $16.8M in Series A funding. Nanovis differentiates itself through its partnership with Medtronic, which acquired exclusive interbody rights to the nanoVIS Ti Surface Technology in 2024. The company engineers and produces nano surface technologies validated through NIH-funded studies, with a multi-system development partnership advancing interbody designs for major OEM partners.
Nanovis
Series ANanovis develops nano-technology-based spinal implants with its proprietary nanoVIS Ti Surface Technology that improves the integration of orthopedic, spinal, and dental implants. The company's FortiCore interbody fusion devices feature deeply porous scaffold and nano-patterned surfaces. Nanovis has achieved regulatory clearance for the industry's first nanotechnology-designated PEEK interbody with porous titanium…
About
Business model
Nanotechnology > Nanoenabled Products > Life Science > Medical Devices > Regenerative Medicine > Hydroxyapatite Based,
Orthopedics > Medical Devices > Therapies > Spinal Devices > Spinal Fusion
Institutional investors
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ See who's investing in High Tech — full fund directory with check size and geography.